Low-calorie Sweeteners Research Articles

Boosting Stevia's sweetness: Growth regulators mitigate salt stress and enhance steviol glycosides

Stevia rebaudiana Bertoni is a plant species with sweet-tasting leaves that can be used as a natural, low-calorie sweetener with potential health benefits. Salt stress can reduce plant growth and productivity, but the application of growth regulators like salicylic acid (SA), methyl jasmonate (MeJ), and spermidine (Spd) can manage various plant abiotic stresses and improve plant growth and productivity. In this work, we investigated the role of exogenous SA, MeJ, and Spd in conferring salt stress tolerance in Stevia by analyzing plant growth, chlorophyll (Chl), total phenolic, total carotenoid content, antioxidant defense system and steviol glycosides. The aim of a recent study was to assess the effects of these regulators on Stevia plants under both individual and combined salt stress conditions. Foliar application of these regulators improved plant growth under salt stress, with moderate salinity stress increasing glycoside compounds. SA was most effective in increasing rebaudioside A (Reb A), while MeJ + Spd combination was best for increasing stevioside (Stv) content. Individual applications of Spd, MeJ, and SA significantly impacted plant growth and antioxidant content, although their combined use was less effective. Spd application under salt stress yielded the highest increases in total carotenoid and Chl a content, while MeJ and Spd together significantly boosted Chl b content. The study found that SA enhanced superoxide dismutase (SOD) activity and reduced catalase (CAT) activity under salt stress, whereas MeJ alone increased both CAT and SOD activity. The distinct responses to Spd, SA, and MeJ suggest varied mechanisms in oxidative stress-induced antioxidant production. Overall, the use of these growth regulators can improve the growth, yield, and nutritional value of Stevia under salt stress, offering significant implications for agriculture and food security.

Consumption of low-calorie sweetened products and intakes of free sugar and energy among UK adults

Abstract Background Policies to reduce free sugar intake in the population often suggest alternative low or no sugar products that may contain low-calorie sweeteners (LCS). However, the health effects of LCS are controversial and little is known about whether free sugar and energy intake differ between people with varying levels of LCS product consumption. This study examines the associations between LCS product consumption and free sugar and energy intake in UK adults from 2008 to 2019. Methods Repeat cross-sectional data from the UK’s National Diet and Nutrition Survey (2008/09 to 2018/19) involve 8304 adults aged ≥18 years (mean 48.7, SD 18.3) with 58.4% being women. Consumption of LCS products (grams/day) were obtained from 4-day diet diaries and participants were categorized into four groups (No-LCS, Low-LCS, Mid-LCS, High-LCS) based on LCS consumption tertiles in 2008/09. Linear regression analysed associations with LCS group, year, their interaction, and adjusted for sociodemographic factors. Results All four groups consumed free sugar (relative to total energy intake) above recommended levels (5% kcal/day) throughout the study period. In 2008/09, the mean free sugar intake for the No-LCS group was 58.1 grams/day, and the mean total energy intake was 1855.7 kcal/day, which were not significantly different from the High-LCS group. Over time, free sugar intake declined by -1.0 g/year (95%CI: -1.4, -0.6) whereas total energy intake declined by -6.0 kcal/year (95%CI: -11.4, -2.1) in the No-LCS group. The High-LCS group showed similar declines leading to no significant difference in mean free sugar and total energy intake between the No-LCS and High-LCS groups in 2018/19. Conclusions In this representative study of UK adults, similar levels of free sugars and total energy intake were observed among those with no LCS and those with the highest LCS product consumption from 2008 to 2019. Absence of LCS product consumption in diets were not associated with higher free sugar intake. Key messages • The high level of LCS product consumption was not associated with lower free sugar intake among UK adults. These finding challenges policies promoting LCS to reduce UK adults’ free sugar intake. • The finding that UK adults consistently consumed free sugar above recommended levels highlights the ongoing need for policy interventions.

Tailoring the natural rare sugars D-tagatose and L-sorbose to produce novel functional carbohydrates

This multidisciplinary study details the biosynthesis of novel non-digestible oligosaccharides derived from rare sugars, achieved through transfructosylation of D-tagatose and L-sorbose by levansucrase from Bacillus subtilis CECT 39 (SacB). The characterization of these carbohydrates using NMR and molecular docking was instrumental in elucidating the catalytic mechanism and substrate preference of SacB. Tagatose-based oligosaccharides were higher in abundance than L-sorbose-based oligosaccharides, with the most representative structures being: β-D-Fru-(2→6)-β-D-Fru-(2→1)-D-Tag and β-D-Fru-(2→1)-D-Tag. In vitro studies demonstrated the resistance of tagatose-based oligosaccharides to intestinal digestion and their prebiotic properties, providing insights into their structure-function relationship. β-D-Fru-(2→1)-D-Tag was the most resistant structure to small-intestinal digestion after three hours (99.8% remained unaltered). This disaccharide and the commercial FOS clustered in similar branches, indicating comparable modulatory properties on human fecal microbiota, and exerted a higher bifidogenic effect than unmodified tagatose. The bioconversion of selected rare sugars into β-fructosylated species with a higher degree of polymerization emerges as an efficient strategy to enhance the bioavailability of these carbohydrates and promote their interaction with the gut microbiota. These findings open up new opportunities for tailoring natural rare sugars, like D-tagatose and L-sorbose, to produce novel biosynthesized carbohydrates with functional and structural properties desirable for use as emerging prebiotics and low-calorie sweeteners.

Association between low-calorie sweetener consumption during pregnancy and child health: A systematic review and meta-analysis.

We examined the association between low-calorie sweeteners (LCS) consumption during preconception, pregnancy, and breastfeeding and child health outcomes. A systematic search of electronic databases in PubMed, Embase, Cumulated Index to Nursing and Allied Health Literature, the Cochrane Library, Scopus, Web of Science, PsycINFO, ProQuest Health and Medical, ClinicalTrials.gov, and Google Scholar was conducted up to 21 September 2023. A random effects model with restricted maximum likelihood estimation was used for the meta-analysis. Seventeen eligible studies were included. The standardised mean difference (SMD) and 95% confidence interval (CI) in birth weight between those who frequently consumed LCS (≥1 serve/day) during pregnancy and those who did not consume LCS was 0.04 (0.00, 0.08) (four cohort studies). Any LCS consumption during pregnancy compared with no consumption was not associated with birth weight [SMD (95% CI) = 0.03 (-0.03, 0.08)] (four cohort studies). Any LCS consumption during pregnancy was not associated with body mass index z-scores. The weighted mean difference (95% CI) was 0.00 (-0.05, 0.06) at birth, 0.06 (-0.29, 0.40) at 6 months, -0.04 (-0.19, 0.10) at 1 year, 0.00 (-0.16, 0.17) at 3 years, and 0.10 (-0.15, 0.34) at 7 years of the child age, compared with no intake (five cohort studies). The odds of being overweight at 1 year among children exposed to LCS during pregnancy was 1.19 (OR [95% CI]: 1.19 [0.81, 1.58]) compared with unexposed children (two cohort studies). The effect sizes were not precise for all the outcomes as the 95% CI indicated the effect estimates could range from small protective to a higher risk. The effect of LCS consumption on child behaviour and cognition was inconsistent. There is not enough evidence to confirm LCS consumption during pregnancy affects birth weight and risk of overweight in children. However, frequent consumption increased birth weight and the risk of overweight at different ages, though the effects were imprecise. More robust research evidence is required as the quality of evidence is low.

Engineering arabinose-to-arabitol conversion in industrial Saccharomyces cerevisiae for sugar beet pulp valorization

Arabitol, a promising low-calorie sweetener for the food industry, faces production challenges due to the high costs and the environmental impact of conventional chemical methods, as well as the inefficiency of biological approaches using native arabitol-producing yeasts.The Saccharomyces cerevisiae GRE3 gene encodes an NADPH-dependent aldose reductase, capable of converting various aldoses to their respective sugar alcohols. By leveraging the enzyme’s broad substrate specificity, the simultaneous conversion of xylose and arabinose into xylitol and arabitol, respectively, was achieved. This study showcases the feasibility of using engineered industrial yeast strains, overexpressing the native GRE3 gene, for the one-step conversion of arabinose to arabitol. Engineered strains (PE2–2-pGRE3, PE2–2-pGRE3-XII5, CA11-pGRE3, CA11-pGRE3-XII5, CAT1- pGRE3 and CAT1- pGRE3-XII5) exhibited successful arabinose-to-arabitol conversion, with a 3.5-fold variation in arabitol concentrations across strains. Further enhancement of the best-performing strain through overexpression of the GAL2 gene significantly improved arabinose transport, resulting in a 1.95-fold increase in arabitol productivity. This engineered strain, free of heterologous genes, also demonstrated its potential by converting arabinose-rich sugar-beet pulp hydrolysate into arabitol, reaching a titer of 15 g/L with a yield of 1 g/g. This study represents the first example of arabitol production from agro-food waste using genome-edited S. cerevisiae strains, which contain no foreign genes, as a versatile and efficient host.

Consumption of Low-Calorie Sweeteners among Children Aged 6 Months to 5 Years in the United States, NHANES 2017–2020

BackgroundAlthough the American Academy of Pediatrics advises against low-calorie sweeteners (LCS) consumption by children <5 y due to potential health and development concerns, the extent of this consumption among these children is unknown. ObjectivesThe objective of this study was to describe the intake, sources, and dietary patterns associated with LCS consumption among United States infants and preschoolers. MethodsWe used cross-sectional 24-h dietary recall data (day 1) among 1497 children aged 6 mo to 5 y from the National Health and Nutrition Examination Survey 2017–2020 prepandemic. Complex survey procedures and sampling weights were applied to compare LCS consumption patterns (prevalence and frequency [times/day] of any LCS, any LCS-containing beverages [LCSBs], and any LCS-containing foods [LCSFs], with each occurrence of consumption = 1 “serving”) across demographic subgroups and to assess the associated nutrients and % of total energy intake (TEI). ResultsThirty-one percent of children aged 6 mo to 5 y consumed ≥1 LCSB and/or LCSF on a given day. The prevalence of LCS consumption increased with age, 10.5% (6 to <12 mo) to 34.3% (2–5 y). Among LCS consumers, mean serving frequency was 1.4 times/d, with no differences by age or sex. Of all LCSBs servings consumed, 64.0% were fruit drinks; 57.8% of all LCSFs servings were non-Greek yogurt. As consumption levels increased from no LCS to >1 serving/d, intake of the following also increased: total sugar (+1.8% TEI, P-trend = 0.04), added sugar (+1.1%, P-trend = 0.048), sodium (+304 mg, P-trend = 0.04), and fiber (+0.8 g, P-trend = 0.01). In contrast, protein intake was lower (−0.7% TEI, P-trend = 0.02). Those consuming 1 LCS serving/d consumed more total energy than LCS nonconsumers (1606 compared with 1401 kcal), but TEI did not increase further with >1 LCS serving/d (1607 kcal). LCS consumption was not associated with carbohydrate or fat intake. ConclusionsLCS consumption, primarily from fruit drinks and non-Greek yogurt, is prevalent among United States preschoolers, and this consumption is associated with greater intake of total sugar, added sugar, and sodium.

Engineering Escherichia coli for D-allulose biosynthesis from glycerol

D-allulose, a naturally occurring monosaccharide, is present in small quantities in nature. It is considered a valuable low-calorie sweetener due to its low absorption in the digestive tract and zero energy for growth. Most of the recent efforts to produce D-allulose have focused on in vitro enzyme catalysis. However, microbial fermentation is emerging as a promising alternative that offers the advantage of combining enzyme manufacturing and product synthesis within a single bioreactor. Here, a novel approach was proposed for the efficient biosynthesis of D-allulose from glycerol using metabolically engineered Escherichia coli. FbaA, Fbp, AlsE, and A6PP were used to construct the D-allulose synthesis pathway. Subsequently, PfkA, PfkB, and Pgi were disrupted to block the entry of the intermediate fructose-6-phosphate (F6P) into the Embden−Meyerhof−Parnas (EMP) and pentose phosphate (PP) pathways. Additionally, GalE and FryA were inactivated to reduce D-allulose consumption by the cells. Finally, a fed-batch fermentation process was implemented to optimize the performance of the cell factory. As a result, the titer of D-allulose reached 7.02 g/L with a maximum yield of 0.287 g/g.

Determination of steviol glycosides in commercial Soju using UPLC-TQ-MS/MS with product ion confirmation scan (PICS) mode

Steviol glycosides (SGs), derived from Stevia rebaudiana, are of increasing interest as potent low-calorie sweetener. However, there is still unclear regulation for estimating the maximum limit of their usage in food products and daily intakes, due to limited information on quantitative analytical protocols for SGs. In the present study, optimized settings for ultraperformance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) with product ion confirmation scan (PICS) mode for separation and quantitation of all 13 SGs were discussed. As a result, UPLC-TQ-MS/MS method with PICS mode presented excellent linearity (R² > 0.999), limits of detection (0.03–0.04 mg/L), and limits of quantitation (0.09–0.12 mg/L), along with high accuracy (recovery 97.4–105.6 %) and precision (RSD 0.35–3.24 %), within 35 min. The validated method was then applied to analyze 10 commercial Korean distilled liquors, Soju. All Soju samples were diluted with a five-fold volume of the acetonitrile (ACN) and deionized water mixture (3:7, v/v) for further analysis. Mostly, rebaudioside A exhibited the highest content with large variation, while both rebaudioside E and O were the lowest content with the smallest variation. The separation and quantitation methods for SGs can be applied for liquid food quality control and the obtained results can be useful to the guideline for daily amounts of drinking Soju for the public.

Low-Calorie Sweeteners and Reproductive Health: Evidence and Debates

The reduction in sugar consumption has led to increased use of low-calorie artificial sweeteners. This coincides with an increase in infertility rates, suggesting that low-calorie artificial sweeteners may negatively affect reproductive health. Low-calorie sweeteners may affect oxidative stress, glucose regulation, and the microbiota, which are associated with reproductive health. Therefore, a review was conducted to examine the effects of commonly used low-calorie sweeteners on reproductive health through potential biological mechanisms. This review addresses the effects of low-calorie sweeteners in a wide range of areas, such as infertility, pregnancy and neonatal health, and early menarche. Recent studies have indicated potential adverse effects of artificial sweeteners on reproductive health. Research has examined the potential impacts of artificial sweeteners on various parameters, such as hormone levels, sperm quality, sperm motility, ovarian function, and pregnancy outcomes. However, the findings of current studies are inconsistent, and these disparate results may stem from metabolic differences among different types of artificial sweeteners, variations in research methodologies, diversity in sample sizes, and fluctuations in study populations. Therefore, further research is needed to comprehensively understand the effects of artificial sweeteners on reproductive health.

In vitro micropropagation and mass multiplication of Stevia rebaudiana Bertoni

Stevia rebaudiana Bertoni, an ancient perennial herb produces steviol glycosides including stevioside and rebaudioside-A that are valuable as low calorie sweeteners, about 300-400 times sweeter than saccharose. Conventional propagation methods are not produce adequate planting material. Micro propagation is an imperative technology that could be extensively exploited to meet the growing demands of elite planting material for commercially cultivated. The prime objective of this study was to established standard protocol for in vitro regeneration and mass multiplication in Stevia. In present investigation, different concentrations of Auxin and Cytokinin were tried for optimization of shoot initiation, shoot multiplication, root initiation and callus induction of Stevia from different explant. BAP and IBA (1.0+0.5) mg/l, IBA (2.0) mg/l shows promising results of shoot multiplication and root initiation respectively.

Production, purification, characterization, and safety evaluation of constructed recombinant D-psicose 3-epimerase

BackgroundD-psicose 3-epimerase (DPEase) is a potential catalytic enzyme for D-psicose production. D-psicose, also known as D-allulose, is a low-calorie sweetener that has gained considerable attention as a healthy alternative sweetener due to its notable physicochemical properties. This research focused on an in-depth investigation of the expression of the constructed DPEase gene from Agrobacterium tumefaciens in Escherichia coli for D-psicose synthesis. Experimentally, this research created the recombinant enzyme, explored the optimization of gene expression systems and protein purification strategies, investigated the enzymatic characterization, and then optimized the D-psicose production. Finally, the produced D-psicose syrup underwent acute toxicity evaluation to provide scientific evidence supporting its safety.ResultsThe optimization of DPEase expression involved the utilization of Mn2+ as a cofactor, fine-tuning isopropyl β-D-1-thiogalactopyranoside induction, and controlling the induction temperature. The purification process was strategically designed by a nickel column and an elution buffer containing 200 mM imidazole, resulting in purified DPEase with a notable 21.03-fold increase in specific activity compared to the crude extract. The optimum D-psicose conversion conditions were at pH 7.5 and 55 °C with a final concentration of 10 mM Mn2+ addition using purified DPEase to achieve the highest D-psicose concentration of 5.60% (w/v) using 25% (w/v) of fructose concentration with a conversion rate of 22.42%. Kinetic parameters of the purified DPEase were Vmax and Km values of 28.01 mM/min and 110 mM, respectively, which demonstrated the high substrate affinity and efficiency of DPEase conversion by the binding site of the fructose-DPEase-Mn2+ structure. Strategies for maintaining stability of DPEase activity were glycerol addition and storage at -20 °C. Based on the results from the acute toxicity study, there was no toxicity to rats, supporting the safety of the mixed D-fructose–D-psicose syrup produced using recombinant DPEase.ConclusionsThese findings have direct and practical implications for the industrial-scale production of D-psicose, a valuable rare sugar with a broad range of applications in the food and pharmaceutical industries. This research should advance the understanding of DPEase biocatalysis and offers a roadmap for the successful scale-up production of rare sugars, opening new avenues for their utilization in various industrial processes.

The Bittersweet Reality: The Cardiovascular Risk of Artificial Sweeteners.

Artificial sweeteners are increasingly popular as alternatives to sugar. Approximately 41% of the American adult population reports regular consumption of low-calorie sweeteners. People are not even aware they are ingesting artificial sweeteners as they are now in chewing gum, toothpaste, various food products, baked goods, and even pharmaceutical products. Some of these sweeteners are sweeter than sugar, some less sweet than sugar, and some are natural sweeteners. With the goal of increasing palatability, many products have multiple additives to create the perfect taste. Despite their widespread use and perceived benefits, there is increasing concern in the academic community about the long-term safety of these artificial sweeteners and their role in increasing the burden of cardiovascular diseases, including coronary heart disease, stroke, and heart failure. There is general agreement about the cardiovascular risk of added sugars to a diet. Public health authorities have recommended limiting added sugar consumption. Replacing sugar with these artificial sweeteners has become increasingly popular, but safety remains a question. While multiple well-designed randomized clinical trials are needed for the conclusion, review of the current literature gives us pause about the cardiovascular risk and long-term safety of these additives.

Association Between Low-Calorie Sweetener Consumption During Pregnancy and Child Growth: A Systematic Review and Meta-Analysis

Association Between Low-Calorie Sweetener Consumption During Pregnancy and Child Growth: A Systematic Review and Meta-Analysis

Monitoring of Sugar and Low-Calorie Sweetener Content in Alcoholic Beverages

Monitoring of Sugar and Low-Calorie Sweetener Content in Alcoholic Beverages

Exploration of Trichoderma reesei as an alternative host for erythritol production

BackgroundErythritol, a natural polyol, is a low-calorie sweetener synthesized by a number of microorganisms, such as Moniliella pollinis. Yet, a widespread use of erythritol is limited by high production costs due to the need for cultivation on glucose-rich substrates. This study explores the potential of using Trichoderma reesei as an alternative host for erythritol production, as this saprotrophic fungus can be cultivated on lignocellulosic biomass residues. The objective of this study was to evaluate whether such an alternative host would lead to a more sustainable and economically viable production of erythritol by identifying suitable carbon sources for erythritol biosynthesis, the main parameters influencing erythritol biosynthesis and evaluating the feasibility of scaling up the defined process.ResultsOur investigation revealed that T. reesei can synthesize erythritol from glucose but not from other carbon sources like xylose and lactose. T. reesei is able to consume erythritol, but it does not in the presence of glucose. Among nitrogen sources, urea and yeast extract were more effective than ammonium and nitrate. A significant impact on erythritol synthesis was observed with variations in pH and temperature. Despite successful shake flask experiments, the transition to bioreactors faced challenges, indicating a need for further scale-up optimization.ConclusionsWhile T. reesei shows potential for erythritol production, reaching a maximum concentration of 1 g/L over an extended period, its productivity could be improved by optimizing the parameters that affect erythritol production. In any case, this research contributes valuable insights into the polyol metabolism of T. reesei, offering potential implications for future research on glycerol or mannitol production. Moreover, it suggests a potential metabolic association between erythritol production and glycolysis over the pentose phosphate pathway.

Effect of perinatal consumption of low-calorie sweetener on maternal health: A systematic review and meta-analysis

Background and AimsEvidence regarding perinatal low-calorie (or artificial) sweetener (LCS) consumption and its effect on maternal health outcomes is limited and inconclusive. The primary outcomes of our systematic review and meta-analysis were the effect of preconception and pregnancy LCS exposure on reproductive and pregnancy outcomes. Secondary outcomes included long-term maternal health . MethodsA systematic search of electronic databases, including PubMed, Embase, CINAHL, the Cochrane Library, Scopus, Web of Science, PsycINFO, ProQuest Health and Medical, ClinicalTrials.gov and Google Scholar, was conducted up to 20 November 2023. Primary studies, including interventional studies, cohort studies, case-control studies, which reported any LCS consumption during perinatal period and pregnancy and maternal health outcomes were eligible. A random effects model with restricted maximum likelihood estimation was used for the meta-analysis. We appraised the quality of the included studies using the National Institute of Health study quality appraisal tool and the overall quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation tool. ResultsA total of 19 eligible studies with 203,706 participants were included. LCS consumption during pregnancy was associated with 11% increased risk of preterm birth (RR = 1.11, 95% CI: 1.07-1.16, I2 = 0.01%) and 42% increased risk of gestational diabetes (RR = 1.42, 95% CI: 0.98-2.04, I2 = 67.60%) compared with no consumption, however, the effect size for gestational diabetes was not precise as the 95% CI indicated that the effect estimate could range from 2% lower risk to 204% (or 2.04 times) higher risk. We found no association between LCS consumption during pregnancy and gestational weight gain (standardized mean difference (SMD) = 0.04; 95% CI: -0.17 - 0.24, I2 = 41.31%) or gestational age at birth (SMD = 0.00; 95% CI: -0.13 – 0.14, I2 = 80.13%). The effect of LCS consumption on reproductive treatment outcomes were inconsistent. ConclusionsBased on the evidence available, LCS consumption in pregnancy was associated with increased risk of preterm birth and gestational diabetes. Robust research, such as well-designed randomized trials and large prospective cohort studies, is required to confirm the causal effect of LCS consumption during perinatal period on adverse maternal health outcomes.

A novel cellobiose 2-epimerase from anaerobic halophilic Iocasia fonsfrigidae and its ability to convert lactose in fresh goat milk into epilactose.

Cellobiose 2-epimerase (CE) has received great attention due to its potential applications in the food and pharmaceutical industries. In this study, a novel CE from mesophilic anaerobic halophilic bacterium Iocasia fonsfrigidae strain SP3-1 (IfCE) was successfully expressed in Escherichia coli and characterized. Unlike other CEs, the purified IfCE shows only epimerization activity toward β-1,4-glycosidic linkages of disaccharides, including mannobiose, cellobiose and lactose, but not for monosaccharides, β-1,4-glycosidic linkages of trisaccharides and α-1,4-glycosidic linkages of disaccharides. Only one epimerization product was obtained from the action of IfCE against mannobiose, cellobiose and lactose. Under optimum conditions, 31.0% of epilactose, a rare and low-calorie prebiotic sweetener with medicinal and pharmacological properties, was obtained from 10 mg mL-1 lactose. IfCE was highly active against lactose under NaCl concentrations up to 500 mmol L-1, possibly due to the excessive basic (arginine and lysine) and acidic (aspartic and glutamic acids) amino acid residues, which are localized on the surface of the halophilic enzyme structure. These residues may protect the enzyme from Cl- and Na+ ions from the environment, respectively. Under normal conditions, IfCE was able to convert lactose present in fresh goat milk to epilactose with a conversion yield of 31% in 10 min. In addition, IfCE has been investigated as a safe enzyme for human allergen. The results suggested that IfCE is a promising candidate to increase the quality and value of milk and dairy products by converting lactose that causes digestive problems in people with lactose intolerance into epilactose. © 2024 Society of Chemical Industry.

Xylitol is prothrombotic and associated with cardiovascular risk.

The pathways and metabolites that contribute to residual cardiovascular disease risks are unclear. Low-calorie sweeteners are widely used sugar substitutes in processed foods with presumed health benefits. Many low-calorie sweeteners are sugar alcohols that also are produced endogenously, albeit at levels over 1000-fold lower than observed following consumption as a sugar substitute. Untargeted metabolomics studies were performed on overnight fasting plasma samples in a discovery cohort (n = 1157) of sequential stable subjects undergoing elective diagnostic cardiac evaluations; subsequent stable isotope dilution liquid chromatography tandem mass spectrometry (LC-MS/MS) analyses were performed on an independent, non-overlapping validation cohort (n = 2149). Complementary isolated human platelet, platelet-rich plasma, whole blood, and animal model studies examined the effect of xylitol on platelet responsiveness and thrombus formation in vivo. Finally, an intervention study was performed to assess the effects of xylitol consumption on platelet function in healthy volunteers (n = 10). In initial untargeted metabolomics studies (discovery cohort), circulating levels of a polyol tentatively assigned as xylitol were associated with incident (3-year) major adverse cardiovascular event (MACE) risk. Subsequent stable isotope dilution LC-MS/MS analyses (validation cohort) specific for xylitol (and not its structural isomers) confirmed its association with incident MACE risk [third vs. first tertile adjusted hazard ratio (95% confidence interval), 1.57 (1.12-2.21), P < .01]. Complementary mechanistic studies showed xylitol-enhanced multiple indices of platelet reactivity and in vivo thrombosis formation at levels observed in fasting plasma. In interventional studies, consumption of a xylitol-sweetened drink markedly raised plasma levels and enhanced multiple functional measures of platelet responsiveness in all subjects. Xylitol is associated with incident MACE risk. Moreover, xylitol both enhanced platelet reactivity and thrombosis potential in vivo. Further studies examining the cardiovascular safety of xylitol are warranted.

Association between Low Calorie Sweetener Consumption Pattern, Anthropometric Indices, and Nutritional Status among Adults’ Males and Females in Calabar Municipality, Nigeria

Aim: This study aimed to investigate the association between low-calorie sweetener (LCS) consumption patterns, anthropometric indices, and nutritional status among adults and women in Calabar Municipality, Nigeria. Study Design; A cross-sectional Analytical design was conducted among 335 participants, selected by multistage sampling technique. Methodology: Dietary assessment using 24hrs recall, anthropometrics measures and socio-demographic characteristics data were collected using pretested questionnaire. The collected data were entered in to Microsoft Excel and exported to SPSS for further statistical analysis. Chi-square test at 95% confidence interval (CI) was used to quantify independent variables of nutritional indices. Using WHO-reference-2010, height, weight and BMI were measured Results: Over 40 products containing LCS were classified into five groups. Carbonated beverages were most consumed, while energy drinks were least consumed. Aspartame was the most commonly used LCS. Young single adults aged 20-35, mostly students, consumed LCS-containing products more frequently than other adults. The overall prevalence of LCS consumption was 58.1%, (moderate), with participants consuming an LCS containing beverage, at least three times a week at an estimated quantity of 1 liter. There was statistical significance (P=.05) differences in weight, waist circumference and hip circumference between men and women. The BMI for men and women were of 22.6 ± 0.9 and 21.0 ± 1.0 kg/m2, respectively. The BMI categories of the study participants were as follows; underweight (3.9%), normal weight (65.7) overweight (28.1) and obese (2.3%). The prevalence of abnormal waist-to-hip ratio was reported, with a significant (P=.05) association between LCS consumption and BMI. Bivariate analysis of LCS consumption and socio-demographic variables found significant association between variables such as gender, age, monthly income and educational level at P=.05. Multivariate logistic regression analysis identified age, income, and BMI as predictors of LCS intake. Conclusion: The study showed that the consumption pattern exists among the adults in terms of age category and gender. Consumption of LCS beverages was mostly moderate, on average around thrice per week and was influenced by demographic factors such as gender, age, and socioeconomic status.

Insight into the interaction and binding mechanism of a natural nonnutritive sweetener mogroside V with soybean protein isolates based on multi-spectroscopic techniques and computational simulations

As a natural low-calorie sweetener, Mogroside V (Mog-V) has gradually become one of the alternatives to sucrose with superior health attributes. However, Mog-V will bring unpleasant aftertastes when exceeding a threshold concentration. To investigate the possibility of soy protein isolates (SPIs), namely β-conglycinin (7S), and glycinin (11S) as flavor-improving agents of Mog-V, the binding mechanism between Mog-V and SPIs was explored through multi-spectroscopy, particle size, zeta potential, and computational simulation. The results of the multi-spectroscopic experiments indicated that Mog-V enhanced the fluorescence of 7S/11S protein in a static mode. The binding affinity of 7S-Mog-V was greater compared with 11S-Mog-V. Particle size and zeta potential analysis revealed that the interaction could promote aggregation of 7S/11S protein with different stability. Furthermore, computational simulations further confirmed that Mog-V could interact with the 7S/11S protein in different ways. This research provides a theoretical foundation for the development and application of SPI to improve the flavor of Mog-V, opening a new avenue for further expanding the market demand for Mog-V.